Table 2.
Baseline demographic and clinical characteristics of patients
| Normal imaging (n = 125, 47.3%) |
Ischemia (n = 65, 24.62%) |
Hemorrhage (n = 25, 9.47%) |
CSVD (n = 49, 18.56%) |
|
|---|---|---|---|---|
| Age (years) | 51 ± 15.8 | 61.6 ± 13.8 | 61 ± 14 | 67 ± 10 |
| Sex (F,%) | 57.6 | 63.1 | 52 | 44.9 |
| Time on dialysis (months) | 43 (5–200) | 56 (6–240) | 48 (5–216) | 34 (6–305) |
| ESRD etiology | ||||
| DM, n (%) | 41 (32,8) | 38 (58.5)* | 13 (52)* | 27 (55)* |
| HT, n (%) | 5 (4) | 4 (6,2) | 5 (20)* | 5 (10) |
| GN, n (%) | 11 (8.8) | 2 (3.1) | 0 (0) | 1 (2) |
| PKD, n (%) | 5 (4) | 2 (3.1) | 0 (0) | 3 (6.1) |
| VUR, n (%) | 1 (0.8) | 0 (0) | 1 (4) | 0 (0) |
| Other, n (%) | 61 (48.8) | 18 (27.7) | 6 (24) | 13 (26.5) |
| Unknown, n (%) | 1 (0.8) | 1 (1.5) | 0 (0) | 0 (0) |
| CAD, n (%) | 36 (28) | 39 (60)* | 12 (48)* | 30 (61)* |
Abbreviations: CAD coronary artery disease; CSVD cerebral small vessel disease; DM diabetes mellitus; ESRD end-stage renal disease; GN glomerulonephritis; HT hypertension; PKD polycystic kidney disease; VUR vesicoureteral reflux
*P ≤ 0.005